Navigation Links
Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting

Presentation Details Statistically Significant Clinical Results for SB-509 in Development for Treatment of Diabetic Neuropathy

CHICAGO, June 22, 2007 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. announced today the presentation of encouraging Phase 1 clinical data from its ZFP Therapeutic(TM) program at the 67th Scientific Sessions of the American Diabetes Association (ADA). As disclosed in an oral presentation entitled, "Improved Neurologic Exam and Nerve Conduction Velocities in Diabetic Neuropathy Patients Treated with Vascular Endothelial Growth Factor (VEGF) Zinc Finger Protein Activator (SB-509)," results of Sangamo's Phase 1b clinical trial demonstrated statistically significant improvements in subjects with diabetic neuropathy. SB-509 is a formulation of a zinc finger DNA-binding protein transcription factor (ZFP TF(TM)) designed to upregulate the expression of the gene encoding vascular endothelial growth factor (VEGF-A). Sangamo is currently evaluating SB-509 in two ongoing Phase 2 clinical trials for the treatment of diabetic neuropathy.

"We are very excited by the significant improvements that we observed in several measurements of nerve health in subjects with mild to moderate diabetic neuropathy over six months after a single administration of SB-509," commented the presenter, Mark Kipnes, M.D., lead investigator on the Phase 1 trial and an endocrinologist at the Diabetes and Glandular Disease Clinic, San Antonio, Texas. "The data obtained in this clinical trial demonstrate that SB-509 appears to have not only a neuroprotective but possibly also a neuroregenerative effect. Currently, the only treatment options are analgesics and antidepressants to control pain symptoms. In contrast, SB-509 is designed to address the actual nerve damage and therefore could have a profound impact on the lives of patients suffering with diabetic neuropathy."

In addition, Sangamo announced today t
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
5. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
6. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
7. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
8. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:5/21/2013)... /PRNewswire-iReach/ -- The 2013 Pharma ChemOutsourcing Show slated for ... number of "Emerging" small molecule biotech company chemists ... .  "No one saw this coming", commented ... still 4 months away and we may end up ... surprise and great news for attendees". Thecurrent list of ...
(Date:5/21/2013)... 21, 2013  IsoRay, Inc. (AMEX: ISR ... entered into an exclusive international distribution agreement with IASIS ... in Greece . IsoRay is a ... medical radioisotope applications for brain cancer, lung cancer, head ... IASIS Medical is ideally suited to ...
(Date:5/21/2013)...  The North Shore-LIJ Health System is expanding a ... at North Shore University Hospital in Manhasset, ... at Forest Hills (NY) Hospital. ... new pilot program strengthens patient safety by providing hospitals ... first time in the US that remote video auditing ...
Breaking Medicine Technology:Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4
(Date:5/21/2013)... Benefit Express Services, LLC, a leader in ... will be hosting a free Workplace Wellness webinar on ... The presentation will focus on making sure your workplace ... Health Care Reform Requirements. The team will also share ... Express regularly hosts free educational webinars on issues that ...
(Date:5/21/2013)... Three major Ohio universities and four hospitals have ... a new collaborative research program aimed exclusively at finding ... Dimes intends to invest $10 million in the program ... Prematurity Research Center -- Ohio Collaborative is a unique ... the March of Dimes. "This new transdisciplinary, team-based research ...
(Date:5/21/2013)... 2013 EMBO announced today that 52 outstanding researchers ... membership. Forty-three of the researchers reside in Europe and ... nine Associate Members from Canada, China, India, Japan and ... 1600 life scientists. , "Our members are the basis ... Maria Leptin said. "We have been building our network ...
(Date:5/21/2013)... Healthcare Solutions, the parent company ... announced that it was honored to receive the ... Conferred annually, the Innovation Award recognizes a ... cutting edge programs that improves cost and/or quality ... for its clinical and IT solutions that have ...
(Date:5/21/2013)... Two-thirds of patients who have been diagnosed ... that they engage in at least one type of ... findings from the National Health and Wellness Survey ... research will be presented today at the 18th Annual ... Outcomes Research) in New Orleans. , “Cancer ...
Breaking Medicine News(10 mins):Health News:Benefit Express to Host Workplace Wellness Webinar 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3Health News:EMBO announces 52 new members for 2013 2Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3
... By Jenifer Goodwin HealthDay Reporter , MONDAY, Sept. ... more likely to suffer socially and emotionally than their normal-weight ... in Australia checked children,s BMI, a measure of height and ... few years later. Parents and teachers filled out questionnaires that ...
... , MONDAY, Sept. 19 (HealthDay News) -- More than ... attack are delayed in getting the emergency artery-opening intervention ... from the fact that only a quarter of American ... that many patients who experience a so-called "ST-segment elevation ...
... D.C. Psychosocial stress could play a role in ... populations, according to study results presented at the Fourth ... held here from Sept. 18-21, 2011. "We found ... reported higher levels of stress than whites, and that ...
... COLUMBIA, Mo. For medications to be effective, they must ... time, as prescribed by healthcare providers. The World Health ... incorrectly, costing the U.S. health care system and consumers ... University of Missouri researchers say medication non-adherence interventions should ...
... effects of cancer treatments. Beth Faiman MSN, ... School of Nursing at Case Western Reserve University, is ... effects for people with blood and bone marrow cancers. ... 1994 at the Cleveland Clinic Taussig Cancer Center with ...
... , MONDAY, Sept. 19 (HealthDay News) -- American youngsters ... than their northern neighbors due to a public health policy ... 4-year olds, according to a Canadian-American research team. The ... the U.S. Advisory Committee on Immunization Practices in 2006. To ...
Cached Medicine News:Health News:Obese Kids May Face Social, Emotional Woes 2Health News:Obese Kids May Face Social, Emotional Woes 3Health News:One-Third of Severe Heart Attack Patients Have Treatment Delays 2Health News:Integrating medication regimens into daily routines can improve adherence 2Health News:CWRU research examines over-the-counter drug's effect on chemo's side effects 2Health News:U.S. Flu Shot Policy Shields More Kids Than Canada's Program, Study Finds 2
... Tango exercise BP monitor is designed to ... and diastolic BP along with heart rate. ... for use in treadmill, ergometer and pharmacological ... for use in research environments., ,Tango ...
...
...
... Tamp is an orthopedic balloon designed to ... Like an angioplasty balloon, it can be ... is inflated with radiopaque contrast medium. The ... volume. The force of balloon growth compacts ...
Medicine Products: